Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Urinary morbidity after 125I b...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Urinary morbidity after 125I brachytherapy of the prostate.
Bibliographic Details
Main Authors:
Henderson, A
,
Bott, SR
,
Sooriakumaran, P
,
Laing, R
,
Langley, SE
Format:
Journal article
Language:
English
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
Biochemical (prostate-specific antigen) relapse-free survival and toxicity after 125I low-dose-rate prostate brachytherapy.
by: Khaksar, S, et al.
Published: (2006)
Brachytherapy: the surgeon's perspective.
by: Henderson, A, et al.
Published: (2004)
Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
by: Nobes, J, et al.
Published: (2008)
Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
by: Nobes, J, et al.
Published: (2008)
COX-2 inhibition: a possible role in the management of prostate cancer?
by: Sooriakumaran, P, et al.
Published: (2007)